Cargando…
Why do results conflict regarding the prognostic value of the methylation status in colon cancers? the role of the preservation method
BACKGROUND: In colorectal carcinoma, extensive gene promoter hypermethylation is called the CpG island methylator phenotype (CIMP). Explaining why studies on CIMP and survival yield conflicting results is essential. Most experiments to measure DNA methylation rely on the sodium bisulfite conversion...
Autores principales: | Tournier, Benjamin, Chapusot, Caroline, Courcet, Emilie, Martin, Laurent, Lepage, Côme, Faivre, Jean, Piard, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293017/ https://www.ncbi.nlm.nih.gov/pubmed/22243995 http://dx.doi.org/10.1186/1471-2407-12-12 |
Ejemplares similares
-
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer
por: Tournier, Benjamin, et al.
Publicado: (2022) -
Microsatellite instability and intratumoural heterogeneity in 100 right-sided sporadic colon carcinomas
por: Chapusot, C, et al.
Publicado: (2002) -
A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma
por: Kientz, Caroline, et al.
Publicado: (2017) -
Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
por: Draht, Muriel X. G., et al.
Publicado: (2016) -
Nutritional supplements and infection in the elderly: why do the findings conflict?
por: Sternberg, Saul, et al.
Publicado: (2006)